Abstract

BackgroundCurrently, revisions to the ICH S1 guidance on rodent carcinogenicity testing are being proposed. Application of this approach would reduce the use of animals in accordance with the 3Rs principles (reduce/refine/replace). The method would also shift resources to focus on more scientific mechanism-based carcinogenicity assessments and promote safe and ethical development of new small molecule pharmaceuticals. In the revised draft, findings such as cellular hypertrophy, diffuse and/or focal cellular hyperplasia, persistent tissue injury and/or chronic inflammation, preneoplastic changes, and tumors are listed as histopathology findings of particular interest for identifying carcinogenic potential. In order to predict hepatocarcinogenicity of test chemicals based on the results from 2- or 4-week repeated dose studies, we retrospectively reanalyzed the results of a previous collaborative study on the liver micronucleus assay. We focused on liver micronucleus induction in combination with histopathological changes including hypertrophy, proliferation of oval cells or bile duct epithelial cells, tissue injuries, regenerative changes, and inflammatory changes as the early responses of hepatocarcinogenesis. For these early responses, A total of 20 carcinogens, including 14 genotoxic hepatocarcinogens (Group A) and 6 non-liver-targeted genotoxic carcinogens (Group B) were evaluated.ResultsIn the Group A chemicals, 5 chemicals (NPYR, MDA, NDPA, 2,6-DNT, and NMOR) showed all of the 6 early responses in hepatocarcinogenesis. Five chemicals (DMN, 2,4-DNT, QUN, 2-AAF, and TAA) showed 4 responses, and 4 chemicals (DAB, 2-NP, MCT, and Sudan I) showed 3 responses. All chemicals exhibited at least 3 early responses.Contrarily, in the Group B chemicals (6 chemicals), 3 of the 6 early responses were observed in 1 chemical (MNNG). No more than two responses were observed in 3 chemicals (MMC, MMS, and KA), and no responses were observed in 2 chemicals (CP and KBrO3).ConclusionEvaluation of liver micronucleus induction in combination with histopathological examination is useful for detecting hepatocarcinogens. This assay takes much less time than routine long-term carcinogenicity studies.

Highlights

  • The liver is an important tissue in general toxicological studies, and in carcinogenicity studies

  • Classification of chemicals and previous collaborative study by CSGMT/The Japanese Environmental Mutagen Society (JEMS) Mammalian Mutagenicity Study Group (MMS) Twenty genotoxic carcinogens examined in a previous collaborative study by CSGMT/JEMS MMS were classified into two groups: Group A consisted of 14 genotoxic hepatocarcinogens and Group B consisted of 6 nonliver-targeted genotoxic carcinogens

  • Group A chemicals We evaluated 14 Group A chemicals for 10 markers of the carcinogenic pathways (9 liver pathological responses and liver micronucleus induction) (Fig.2)

Read more

Summary

Introduction

The liver is an important tissue in general toxicological studies, and in carcinogenicity studies. The approach used 2or 4-week repeated-dose treatment for the accumulation of micronucleated hepatocytes (MNHEPs) [19] This method facilitates the integration of the liver micronucleus assay into repeated-dose general toxicity studies to simultaneously assess genotoxicity and histopathological endpoints with the same animals used for the overall evaluation of chemical risk. We focused on liver micronucleus induction in combination with histopathological changes including hypertrophy, proliferation of oval cells or bile duct epithelial cells, tissue injuries, regenerative changes, and inflammatory changes as the early responses of hepatocarcinogenesis. For these early responses, A total of 20 carcinogens, including 14 genotoxic hepatocarcinogens (Group A) and 6 non-livertargeted genotoxic carcinogens (Group B) were evaluated

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call